These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38060822)

  • 1. Harnessing Endogenous Peptide Compounds as Potential Therapeutics for Severe Influenza.
    West AC; Harpur CM; Le Page MA; Lam M; Hodges C; Ely LK; Gearing AJ; Tate MD
    J Infect Dis; 2024 Aug; 230(2):e384-e394. PubMed ID: 38060822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection.
    Harpur CM; West AC; Le Page MA; Lam M; Hodges C; Oseghale O; Gearing AJ; Tate MD
    Clin Transl Immunology; 2023; 12(3):e1443. PubMed ID: 36969366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total alkaloids from Alstonia scholaris inhibit influenza a virus replication and lung immunopathology by regulating the innate immune response.
    Zhou HX; Li RF; Wang YF; Shen LH; Cai LH; Weng YC; Zhang HR; Chen XX; Wu X; Chen RF; Jiang HM; Wang C; Yang M; Lu J; Luo XD; Jiang Z; Yang ZF
    Phytomedicine; 2020 Oct; 77():153272. PubMed ID: 32702592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection.
    Traboulsi H; Cloutier A; Boyapelly K; Bonin MA; Marsault É; Cantin AM; Richter MV
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6317-27. PubMed ID: 26248373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A panel of janus kinase inhibitors identified with anti-inflammatory effects protect mice from lethal influenza virus infection.
    Yu Y; Chen S; Zhang H; Duan Y; Li Z; Jiang L; Cao W; Peng Q; Chen X
    Antimicrob Agents Chemother; 2024 Apr; 68(4):e0135023. PubMed ID: 38470034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saikosaponin A inhibits influenza A virus replication and lung immunopathology.
    Chen J; Duan M; Zhao Y; Ling F; Xiao K; Li Q; Li B; Lu C; Qi W; Zeng Z; Liao M; Liu Y; Chen W
    Oncotarget; 2015 Dec; 6(40):42541-56. PubMed ID: 26637810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral burden, inflammatory milieu and CD8
    Nüssing S; Mifsud E; Hensen L; Koutsakos M; Wang Z; Kedzierski L; Mercuri F; Rossignol JF; Hurt AC; Kedzierska K
    Influenza Other Respir Viruses; 2020 Nov; 14(6):678-687. PubMed ID: 32588557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment.
    Marathe BM; Mostafa HH; Vogel P; Pascua PNQ; Jones JC; Russell CJ; Webby RJ; Govorkova EA
    Antiviral Res; 2017 Dec; 148():20-31. PubMed ID: 29100887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleomycin-Induced Lung Injury Increases Resistance to Influenza Virus Infection in a Type I Interferon-Dependent Manner.
    Seo SU; Jeong JH; Baek BS; Choi JM; Choi YS; Ko HJ; Kweon MN
    Front Immunol; 2021; 12():697162. PubMed ID: 34484196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sangju Cold Granule exerts anti-viral and anti-inflammatory activities against influenza A virus in vitro and in vivo.
    Gao T; Liu J; Huang N; Zhou Y; Li C; Chen Y; Hong Z; Deng X; Liang X
    J Ethnopharmacol; 2024 Nov; 334():118521. PubMed ID: 38969152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease.
    Ji S; Bai Q; Wu X; Zhang DW; Wang S; Shen JL; Fei GH
    Biomed Pharmacother; 2020 Jan; 121():109652. PubMed ID: 31734578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus.
    Fukushi M; Yamashita M; Miyoshi-Akiyama T; Kubo S; Yamamoto K; Kudo K
    PLoS One; 2012; 7(8):e42419. PubMed ID: 22879974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-activated dendritic cells ameliorate influenza A infections.
    Boonnak K; Vogel L; Orandle M; Zimmerman D; Talor E; Subbarao K
    J Clin Invest; 2013 Jul; 123(7):2850-61. PubMed ID: 23934125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo anti-influenza virus activity of a zinc finger peptide.
    Judd AK; Sanchez A; Bucher DJ; Huffman JH; Bailey K; Sidwell RW
    Antimicrob Agents Chemother; 1997 Mar; 41(3):687-92. PubMed ID: 9056014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of peramivir against H5N1 highly pathogenic avian influenza viruses harboring the neuraminidase H275Y mutation.
    Kobayashi M; Kodama M; Noshi T; Yoshida R; Kanazu T; Nomura N; Soda K; Isoda N; Okamatsu M; Sakoda Y; Yamano Y; Sato A; Kida H
    Antiviral Res; 2017 Mar; 139():41-48. PubMed ID: 28012921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection.
    Leyva-Grado VH; Ermler ME; Schotsaert M; Gonzalez MG; Gillespie V; Lim JK; García-Sastre A
    mBio; 2017 Mar; 8(2):. PubMed ID: 28351919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral effect of fufang yinhua jiedu (FFYH) granules against influenza A virus through regulating the inflammatory responses by TLR7/MyD88 signaling pathway.
    Zhang Y; Wang R; Shi W; Zheng Z; Wang X; Li C; Zhang S; Zhang P
    J Ethnopharmacol; 2021 Jul; 275():114063. PubMed ID: 33813013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome.
    Baranovich T; Jones JC; Russier M; Vogel P; Szretter KJ; Sloan SE; Seiler P; Trevejo JM; Webby RJ; Govorkova EA
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2118-31. PubMed ID: 26787699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of rosuvastatin in a murine model of influenza A infection.
    Radigan KA; Urich D; Misharin AV; Chiarella SE; Soberanes S; Gonzalez A; Perlman H; Wunderink RG; Budinger GR; Mutlu GM
    PLoS One; 2012; 7(4):e35788. PubMed ID: 22536437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spleen tyrosine kinase inhibitor R406 has both antiviral and anti-inflammatory effects on severe influenza A infection.
    Luo J; Gao Y; Guo W; Zhao S; Li L; Zhang Z; Gao R
    J Med Virol; 2024 May; 96(5):e29678. PubMed ID: 38751128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.